Skip to main content

Peer Review reports

From: Identification of new candidate biomarkers to support doxorubicin treatments in canine cancer patients

Original Submission
8 Feb 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
18 Mar 2021 Reviewed Reviewer Report
22 Mar 2021 Reviewed Reviewer Report
28 Apr 2021 Reviewed Reviewer Report - Gerald Post
6 Jul 2021 Author responded Author comments - Silvia Balbo
Resubmission - Version 4
6 Jul 2021 Submitted Manuscript version 4
16 Jul 2021 Reviewed Reviewer Report - Gerald Post
18 Jul 2021 Reviewed Reviewer Report
3 Aug 2021 Reviewed Reviewer Report
18 Sep 2021 Author responded Author comments - Silvia Balbo
Resubmission - Version 5
18 Sep 2021 Submitted Manuscript version 5
28 Sep 2021 Author responded Author comments - Silvia Balbo
Resubmission - Version 6
28 Sep 2021 Submitted Manuscript version 6
11 Oct 2021 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
13 Oct 2021 Editorially accepted
7 Dec 2021 Article published 10.1186/s12917-021-03062-x

You can find further information about peer review here.

Back to article page